Phase 2 Readout
NTHI: Phase 2 Readout: neo100
June 30, 2026 · neo100. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 30, 2026
- Company
- NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI)
- Drug
- neo100
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: neo100
- Drug
- neo100
- Indication
- IDH-1 mutant Recurrent High‑Grade Glioma